With 20 placements of Mako's surgical robots in the final quarter of 2014, Stryker CEO Kevin Lobo is confident in the $1.7 billion acquisition – and in Stryker's ability to integrate future acquisitions.
Stryker (NYSE:SYK) posted a stellar quarter of sales for the robotic surgical system it acquired in its $1.7 billion deal for Mako Surgical.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1CchcDI
Cap comentari:
Publica un comentari a l'entrada